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BY-NC-ND license (http://creativecomAbstract Background/Purpose: This prospective before-after study was intended to investi-
gate the effect of Bio-Kil on reducing environmental bacterial burden and healthcare-
associated infections (HAIs) in intensive care units (ICUs) at the Municipal Wan-Fang Hospital,
Taipei, Taiwan in 2014.
Methods: Four rooms in the medical and surgical ICUs were investigated and designated as
study rooms (n Z 2) or control rooms (n Z 2). Routine disinfection was performed during
the pre-intervention period in both room types. Bio-Kil was applied to the fomites and sur-
roundings of the study rooms during the intervention period. Total bacterial burden and pro-
portion of colonization of fomites and surroundings by multidrug-resistance organisms
(MDROs) were determined before and after the intervention. The demographic characteristics,
underlying conditions, and clinical outcomes of patients were analyzed.Infectious Disease, Taipei City Hospital and National Yang-Ming University, School of Medicine,
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10.1016/j.jmii.2016.04.008Results: After application of Bio-Kil, the bacterial burden declined in both groups, although
the reduction was greater in the study rooms as compared with the control rooms
(p Z 0.001). During the pre-intervention period, 16 patients were admitted to control rooms
and 18 patients to study rooms. After the intervention, 22 patients were admitted to control
rooms and 21 patients to study rooms. The number of cases of new-onset sepsis declined in the
intervention group (from 33% to 23.8%), but increased in the control group (from 25% to 40.9%);
however, there was no significant difference in incidence of new-onset sepsis between the
study and control rooms after intervention.
Conclusion: Application of Bio-Kil reduced the environmental bacterial burden and MDROs in
ICUs. Further studies are needed to evaluate the efficacy of this nanotechnology-based disin-
fectant in reducing HAIs.
Copyright ª 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
There is compelling evidence that contaminated inanimate
surfaces are major sources of hospital-acquired infections
(HAIs).1e4 Many important nosocomial pathogens, such as
methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant enterococci (VRE), carbapenem-
resistant Enterobacteriaceae (CRE), carbapenem-resistant
Pseudomonas aeruginosa (CRPA), and carbapenem-
resistant Acinetobacter calcoaceticus-baumannii complex
(CRAB), can survive for days to weeks on dry inanimate
surfaces.5 Patients admitted to rooms previously colonized
with these pathogens are at increased risk of colonization or
infection.6e8 Additionally, previous research found that the
frequency of MRSA contamination was similar for healthcare
personnel who either had direct contact with a colonized/
infected patient or with contaminated surfaces.9 Therefore,
decontamination and disinfection of hospital environmental
surfaces is an important infection-control measure.
Environmental decontamination involves the use of
water, detergents, and, increasingly, a disinfectant or
microbiocide, although the effectiveness of any agent de-
pends on how it is applied and the meticulousness of the
decontamination. A previous study of environmental disin-
fection of intensive care units (ICUs) indicated that < 50%
of surfaces were cleaned adequately; however, after
implementation of an infection-control intervention pro-
gram, including the use of ultraviolet monitors as surrogate
markers for bacterial contamination,w82% of fomites were
adequately disinfected.10 Other studies revealed that many
room surfaces remained inadequately disinfected.11,12
Several manufacturers have developed room-disinfection
units that can decontaminate environmental surfaces and
objects by non-touch methods that employ either UV radi-
ation13 or hydrogen-peroxide vapor.14 These methods,
however, can only be used for terminal disinfection of a
discharged room and cannot be used for daily room disin-
fection.11,15 Recently, self-disinfecting surfaces were
developed to reduce the biological burden on environ-
mental surfaces during hospitalization.16
Bio-Kil [3-(Trimethoxysilyl) propyloctadecyldimethyl
ammonium chloride; Cargico Group, Taipei, Taiwan) is an
antimicrobial nanomaterial consisting of inorganic metal
components and organic quaternary ammoniumLee W-S, et al., Bio-Kil, a nano-
ensive care units, Journal of Miccomponents.17 Bio-Kil molecules have a high-affinity
structure and a strong electric field that attracts patho-
gens. The strong electrical charge damages the membrane
proteins of microorganisms, thereby killing the pathogens.
Bio-Kil forms a permanent covalent bond with the surface
of many products, including plastic, paint, and textiles.17
Previous research indicated that use of Bio-Kil in an ICU
effectively reduced the bacterial burden in that environ-
ment18,19; however, the effect of this reduction in bac-
terial burden on the incidence of HAIs has not yet been
documented. Therefore, we performed this prospective
beforeeafter study to determine the efficacy of Bio-Kil on
HAIs and bacterial colonization in ICUs.Methods
Study design and setting
This prospective, open-label, before-after study with con-
trol and intervention groups was conducted in the Medical
and Surgical ICUs (MICUs and SICUs) of the Municipal Wan-
Fang Hospital, a 750-bed teaching hospital in Taipei,
Taiwan, from May 2014 to October 2014. Two rooms each
from the MICU (MICU-15 and MICU-16) and SICU (SICU-21
and SICU-22) were selected for study. MICU-16 and SICU-22
were designated as the study rooms, and MICU-15 and SICU-
21 served as the control rooms. These rooms were selected
for the study, because they were situated at the far end of
the ICU and were separated from the other rooms. The
primary objective of this study was to assess the efficacy of
Bio-Kil in reducing bacterial burden in ICUs. The secondary
objective was to evaluate whether reducing bacterial
burden in patient surroundings prevented nosocomial in-
fections. The study protocol was approved by the Taipei
Medical University-Joint Institutional Review Board (study
protocol TMU-JIRB 201311029).
The three periods of this study were the pre-
intervention period (from May 1, 2014 to July 22, 2014),
the Bio-Kil-setup period (from July 29, 2014 to August 4,
2014), and the intervention period (from August 4, 2014 to
October 20, 2014). During the pre-intervention period,
environmental samples were collected from 17 sites from
each study area and from patients twice weekly. During thebased disinfectant, reduces environmental bacterial burden and
robiology, Immunology and Infection (2016), http://dx.doi.org/
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and their surroundings, were disinfected with Bio-Kil. The
room walls, ceilings, and air-conditioning filters were also
treated with Bio-Kil, and the surfaces of instruments (me-
chanical ventilators, telephones, and computer key pads)
were covered with Bio-Kil-embedded silicon pads. During
this period, no specimen collection was performed.
During the intervention period, textiles, including pillow
cases, bed sheets, and mattresses, were replaced with
textiles that had been washed in a solution of Bio-Kil as
previously described.19 The nurses assigned to care for
patients in the study rooms also wore clothing embedded
with Bio-Kil. Specimen collection followed the same
methods employed during the pre-intervention period.
Routine infection-control measures, environmental
decontamination, textile washing, and
replacement
During the pre-intervention and intervention periods,
textile washing and replacement, infection-control prac-
tices of nurses, physicians, and visitors, and disinfection of
environments and instruments in all ICUs were performed
according to hospital regulations. Daily disinfection of
rooms in the ICUs comprised the application of a 500-ppm
solution of sodium hypochlorite for routine cleaning. Based
on the status of environmental contamination found during
the 1st week of the pre-intervention period and for ethical
considerations, the frequency of changing pillow cases
increased from every other day to daily from the 2nd week
to the end of this study period (including pre-intervention
and intervention periods). Additionally, the cleaners who
performed the routine disinfection measures in the control
and study rooms were trained in more stringent cleaning
practices and to focus on areas that had been shown in the
pre-intervention period as having a high degree of bacterial
burden. Otherwise, the frequency of cleaning and changing
of textiles was the same in all study rooms in the pre-
intervention and intervention periods. All staff members
were monitored for adherence to hand-hygiene practices in
both ICUs throughout the study period.
Specimen collection, bacterial identification, and
susceptibility testing
Specimens for microbiological isolation were collected
twice weekly (Monday and Thursday) from the anterior
nares and rectum of patients, high-contact areas in patient
environments (Figure 1), and from nurse uniforms. We
collected the specimens from swab cultures of fomites,
surroundings, and healthcare-related sites after the daily
routine cleaning work throughout both study periods.
Samples were collected from 17 sites from each study area
(control and study), and all specimens were recorded
separately. For analytical purposes, these collection sites
were classified as: (1) fomites if they were in direct contact
with the patient (pillow cases, bed sheets, mattresses, and
bed rails); (2) patient surroundings if they had no direct
contact with patients (walls surrounding patient beds,
curtains, electrocardiogram monitors, dining tables, cup-
boards, and chart covers); or (3) healthcare worker-relatedPlease cite this article in press as: Lee W-S, et al., Bio-Kil, a nano-
multidrug-resistant organisms in intensive care units, Journal of Mic
10.1016/j.jmii.2016.04.008sites (surfaces of working stations, telephone handsets,
computer keyboards, and sleeves and fronts of nurse
uniforms).
Moistened, sterile, cotton swabs were used to evenly
wipe a designated square (10 cm  10 cm) on each
collection site. Samples were then inoculated into trypti-
case soy agar and inoculated at 35C under 5% CO2 condi-
tions. After 48 hours, colony forming units (CFUs/100 cm2)
were determined. Bacterial species identification and
antimicrobial susceptibility testing were performed using
the Becton Dickinson Phoenix System (Becton Dickinson
Diagnostics, Sparks, MD, USA). Antimicrobial susceptibility
results were interpreted according to Clinical and Labora-
tory Standards Institute guidelines.20 We compared mean
bacterial counts from specimens before and after applica-
tion of Bio-Kil in the intervention group and during the pre-
intervention and intervention periods in the control group.
In this study, multidrug-resistant organisms (MDROs),
including MRSA, VRE, CRE, CRPA, and CRAB, and the inci-
dence of MDROs from each collection were determined.
Patient characteristics
For all patients admitted to the assigned rooms, de-
mographic characteristics, underlying conditions, Acute
Physiology and Chronic Health Evaluation II (APACHE II)
score within 24 hours of admission, microorganisms isolated
from all clinical specimens, and clinical outcomes were
determined. A patient was defined as colonized with a
MDRO if any MDRO was isolated from a clinical specimen
within 3 months prior to admission to the assigned room.
Inclusion criteria and outcome definitions
Only patients who resided in an assigned room for
> 24 hours were included in the analysis. New-onset sepsis
was defined as the development of sepsis after 48 hours of
admission to assigned rooms or within 48 hours of leaving
those rooms.21 The 30-day mortality rate was defined as
overall mortality in the 30 days after admission to the
assigned room. Patients were assessed for development of
any allergic reaction (skin rash or erythema on the next
day) related to Bio-Kil, such as contact dermatitis or
related respiratory reactions.
Statistical analysis
We used the Chi-square test or Fisher’s exact test for cat-
egorical comparisons of data. Differences in means of
continuous variables were tested by the independent t test.
Changes in bacterial colony counts and incidence of new-
onset sepsis in the pre- and post-intervention periods
were determined by a two-proportion z test. Binary logistic
regression analysis was used to identify factors associated
with the development of new-onset sepsis and 30-day
mortality. All significant variables from the univariate an-
alyses were included in a multivariate logistic regression
model for calculation of odds ratios (ORs). A p < 0.05 was
considered statistically significant, and all tests were two-
tailed. All statistical analyses were performed with the
SPSS version 21 (IBM Corp., Armonk, NY, USA).based disinfectant, reduces environmental bacterial burden and
robiology, Immunology and Infection (2016), http://dx.doi.org/
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Figure 1. Schematic of patient areas and sites of specimen collection. Fomites (inanimate objects in direct contact with pa-
tients): 1a/1A, pillowcase; 1b/1B, bed sheet; 1c/1C, mattress; and 1d/1D, bed rails. Patient surroundings (inanimate objects with
no direct patient contact): 2a/2A, wall surrounding patient bed; 2b/2B, curtains; 2c/2C, electrocardiogram monitor; 2d/2D, dining
table; 2e/2E, patient chart cover; and 2f/2F, bedside cupboard.
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Counts of bacteria and MDROs before and after
intervention
We collected specimens 41 times during the pre-
intervention period (20 from MICUs and 21 from SICUs) and
47 times during the intervention period (24 from MICUs and
23 from SICUs). A total of 697 samples collected during the
pre-intervention period and 799 samples collected during
the intervention period were analyzed according to the sites
from which they had been obtained: fomites, surroundings
(Table 1), and healthcare worker-related sites (Figure 2).
Mean CFU/100 cm2 and proportion of isolation of MDROs
from each sample collection are summarized in Table 1.
In the control and study rooms, the mean bacterial
colony counts from samples isolated from fomites were
significantly greater than those isolated from the sur-
roundings during each period. After the intervention, the
average colony counts from samples taken from fomites
declined similarly in control rooms (78.3%) and study rooms
(75.3%); however, during the intervention period, bacterial
counts in the surroundings of the study rooms were signif-
icantly lower than those observed in the surroundings of the
control rooms (80.5% vs. 3.3%, p Z 0.001; Figure 3).
Relative to the control rooms, the study rooms also had
greater declines in overall MDROs isolated from fomites
(45.8% vs. 34.6%, p Z 0.002) and from the surroundings
(83.1% vs. 65.1%, p Z 0.004) after application of Bio-Kil
(Figure 4). However, analysis of MRSA, VRE, and CRAB col-
onies did not reveal a significant decline, most likely
because of the limited case numbers in the study. There
was only one isolate of CRPA during the pre-intervention
period and one isolate of CRE during the post-intervention
period (data not shown) (see Figure 5).Please cite this article in press as: Lee W-S, et al., Bio-Kil, a nano-
multidrug-resistant organisms in intensive care units, Journal of Mic
10.1016/j.jmii.2016.04.008Patient characteristics
Table 2 shows the demographic characteristics, underlying
conditions, and clinical outcomes of all patients. During the
pre-intervention period, 16 patients were admitted to
control rooms, and 18 patients were admitted to study
rooms. During this period, control patients were more likely
to be on ventilator support as compared with intervention
patients (68.8% vs. 33.3%, p Z 0.039), but less likely to
suffer from heart disease (18.8% vs. 72.2%, p Z 0.002).
There were no significant differences in disease severity on
admission (APACHE II score) or in the prevalence of previous
bacterial colonization between the two groups. After the
intervention, 22 patients were admitted to control rooms
and 21 patients were admitted to study rooms. Patients
admitted to the study rooms had higher mean APACHE II
scores on admission (20 vs. 14, p Z 0.004) and were more
likely to have cancer (33.3% vs. 0%, p Z 0.033).
Clinical outcomes
During the pre-intervention period, the incidence of new-
onset sepsis was higher in the study rooms as compared
with the control rooms (33.3% vs. 25%); however, during the
intervention period, the incidence of new-onset sepsis
decreased in the study rooms and increased in the control
rooms (from 33% to 23.8% vs. from 25% to 40.9%,
pZ 0.001). Interestingly, when the incidence of new-onset
sepsis was compared between the control and study rooms,
we found that there was no significant difference in pro-
portion between the two groups (40.9% vs. 23.8%,
p Z 0.232). Possible infection foci and microorganisms
isolated from patients with new-onset sepsis are summa-
rized in Table 2. The most common infection focus in pa-
tients with new-onset sepsis was the respiratory tract, andbased disinfectant, reduces environmental bacterial burden and
robiology, Immunology and Infection (2016), http://dx.doi.org/
Table 1 Bacterial colony counts and MDROs isolated during the pre-intervention and intervention periods in control and study beds.
Pre-intervention period Intervention period Percentage change pa
Control rooms Study rooms Control rooms Study rooms Control rooms Study rooms
Mean bacterial colony count (CFU/100 cm2) in each specimen collectionb
Specimen
collection
(n)
Mean
CFUs/
100
cm2
Specimen
collection
(n)
Mean
CFUs/
100
cm2
Specimen
collection
(n)
Mean
CFUs/
100
cm2
Specimen
collection
(n)
Mean
CFUs/
100
cm2
Fomites 41 11098 41 12962 47 2409 47 3208 78.3 75.3 0.001
Surroundings 41 1835 41 3252 47 1775 47 635 3.3 80.5 0.001
Incidence of MDROs (percentage of total specimens)c
Specimen
collection
(n)
MDRO
incidence
(%)
Specimen
collection
(n)
MDRO
incidence
(%)
Specimen
collection
(n)
MDRO
incidence
(%)
Specimen
collection
(n)
MDRO
incidence
(%)
Fomites
All MDROsd 41 19.5 41 19.5 47 12.8 47 10.6 34.6 45.8 0.002
MRSA 41 9.8 41 2.4 47 2.1 47 0 78.2 100.0 0.261
VRE 41 4.9 41 9.8 47 10.6 47 4.2 118.1 56.6 0.261
CRAB 41 9.8 41 9.8 47 0 47 6.4 100.0 34.9 0.135
Patient surroundings
All MDROs 41 12.2 41 12.1 47 4.3 47 2.1 65.1 83.1 0.004
MRSA 41 4.9 41 4.9 47 0 47 0 100.0 100.0 0.333
VRE 41 7.3 41 2.4 47 0 47 0 100.0 100.0 0.135
CRAB 41 2 .4 41 2.4 47 4.3 47 2.1 74.5 57.9 0.135
a Values based on the two-proportion z test; p < 0.05 was considered significant.
b Mean bacterial colonies in each specimen collection in CFU/100 cm2.
c MDROs include MRSA, VRE, CRE, CRPA, and CRAB.
d If one single type ofMDROwas isolated at the same time fromdifferent specimens of the samepatient, the incidencewas calculated as one.
CFU Z colony forming unit; CRAB Z carbapenem-resistant Acinetobacter calcoaceticus baumannii complex; CRE Z carbapenem-resistant Enterobacteriaceae; CRPA Z carbapenem-
resistant Pseudomonas aeruginosa; MDRO Z multidrug-resistance organisms; MRSA Z methicillin-resistant Staphylococcus aureus; VRE Z vancomycin-resistant enterococci.
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Figure 2. Mean bacterial colony counts (CFUs/100 cm2) in different locations of the MICU and the SICU before and after the
intervention. Public areas: surfaces of workstations, telephone handsets, and computer keyboards. Uniforms: sleeves and fronts of
nurse uniforms. CFU Z colony forming unit; MICU Z medical intensive care unit; SICU Z surgical intensive care unit.
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+ MODELthe majority of cases of sepsis in both groups were due to
Enterobacteriaceae (60% in the intervention group and 44%
in the control group) (see Figure 6).
Safety and side effects
There were no cases of contact dermatitis or other adverse
effects during the study period. Additionally, none of the
nurses who wore clothes treated with Bio-Kil reported any
discomfort.Discussion
The application of Bio-Kil resulted in a self-disinfecting
surface with broad-spectrum antimicrobial activity that0
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10.1016/j.jmii.2016.04.008produced little or no toxicity to humans.16 The efficacy of
these self-disinfecting surfaces in the prevention of HAIs
has not yet been proven. To the best of our knowledge, the
present study is the first to evaluate the clinical outcomes
of patients who reside in ICU rooms that have been treated
with Bio-Kil.
We found that total bacterial counts in samples from
fomites were w80- to 100-fold higher than those observed
in samples taken from the surroundings. Numerous studies
evaluated environmental contamination by
MDROs,1,3,4,7,22,23 but most focused on contamination of
frequently contacted surfaces in hospital environments.
Fomites play an important role in transmission of
microorganism-related diseases.24 Textiles and clothing
that are in direct contact with patients can harbor large
numbers of bacteria and can be a source of hospital%
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Figure 4. Incidence of MDROs in samples taken from fomites and patient surroundings before and after the intervention. MDROs
include MRSA, VRE, CRAB, CRE, and CRPA. MDRO incidence refers to the percentage of specimens that were MDRO.
CRABZ carbapenem-resistant Acinetobacter calcoaceticus baumannii complex; CREZ carbapenem-resistant Enterobacteriaceae;
CRPA Z carbapenem-resistant Pseudomonas aeruginosa; MRDO Z multidrug-resistant organisms; MRSA Z methicillin resistant
Staphylococcus aureus; VRE Z vancomycin resistant enterococci.
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+ MODELcontamination. We found that fomites and textiles coated
with Bio-kil were less likely to be a source of bacterial
growth as compared with untreated surfaces, thereby
reducing the risk of fomite transmission of infection in the
ICU setting (Figure 2).
Our findings confirmed those in previous reports that
Bio-Kil reduces bacterial colonization of patient environ-
ments.18,19 An interesting finding was that bacterial colony
counts declined in study rooms and in control rooms. The
fact that the frequency of changing pillowcases was
increased from every other day to daily after the pre-
intervention period, and that the cleaners who performed
the routine disinfection measures in the control and study
rooms were retrained to focus on areas shown during the
pre-intervention period to have a high degree of bacterial0.0
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Figure 5. Incidence of new-onset sepsis before and after
intervention.
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10.1016/j.jmii.2016.04.008burden during the intervention period most likely contrib-
uted to this specific finding. Nonetheless, the number of
colony counts in samples taken from patient surroundings
after the application of Bio-Kil was significantly lower as
compared with samples taken from control rooms
(Figure 3). We proposed that the fomites were more
affected by vigilant disinfection as compared with the
surroundings, because they were not as close to the patient
bedside as fomites. These results indicated that disinfec-
tion with Bio-Kil resulted in markedly lower bacterial
burden as compared with stringent manual surface cleaning
in ICUs.
The National Health Insurance (NHI) system in Taiwan
covers a wide range of out- and inpatient services and al-
lows people in Taiwan to have access to comprehensive
medical care. However, the introduction of the NHI system
has increased the numbers of bedridden patients and the
long-term use of invasive medical devices,25 which has, in
turn, led to increases in rates of HAIs caused by MDROs,
especially CRAB, CRE, and VRE.26 Moreover, the increase in
average life expectancy and the growth of the elderly
population in Taiwan have led to an increased number of
people living in long-term care facilities,25 which can be
reservoirs of MDROs. A previous study in Chicago, USA re-
ported a higher prevalence of Klebsiella pneumoniae
carbapenemase-producing Enterobacteriaceae in long-term
care hospitals relative to short-stay ICUs.27 In Taiwan, the
incidence of community acquired infections due to patho-
gens once classified as nosocomial has also increased
recently.28,29 In our study, w15e30% of patients were
colonized with an MDRO at admission. Ake et al30 observed
that an initially clean and new trauma-surgical unit quickly
became contaminated by MDROs. The researchers usedbased disinfectant, reduces environmental bacterial burden and
robiology, Immunology and Infection (2016), http://dx.doi.org/
Table 2 Demographic factors, underlying conditions, and clinical outcomes of enrolled patients.
Pre-intervention Intervention
Control rooms
(n Z 16)
Study rooms
(n Z 18)
p Control rooms
(n Z 22)
Study rooms
(n Z 21)
p
Male 7 (43.8) 10 (55.6) 0.492 11 (50.0) 11 (52.4) 0.876
Age in years 70 (15) 77 (17) 0.220 65 (17.2) 73 (14.2) 0.121
APACHE II score 20 (8) 21 (8) 0.752 14 (6.6) 20 (6.6) 0.004
Length of ICU stay 10.8 (10.3) 9.2 (7.7) 0.624 22 (4.9) 21 (6.1) 0.578
Underlying condition
Mechanical ventilation 11 (68.8) 6 (33.3) 0.039 10 (45.5) 13 (61.9) 0.280
Bed-ridden status 7 (43.8) 5 (27.8) 0.331 7 (31.8) 9 (42.9) 0.454
DM 5 (31.3) 5 (27.8) 0.824 3 (13.6) 6 (28.6) 0.229
ESRD 3 (18.8) 3 (16.7) 0.874 5 (22.7) 5 (23.8) 0.933
Cirrhosis 1 (6.3) 1 (5.6) 0.932 0 (0.0) 3 (14.3) 0.066
Cancer 5 (31.3) 2 (11.1) 0.147 0 (0.0) 7 (33.3) 0.003
Heart disease 3 (18.8) 13 (72.2) 0.002 11 (50.0) 8 (38.1) 0.432
COPD 5 (31.3) 4 (22.2) 0.551 1 (4.5) 5 (23.8) 0.068
Previous microbiological results
Previous colonization with MDROs 5 (31.3) 2 (11.1) 0.147 6 (27.3) 4 (19.1) 0.523
Types of MDROs colonizeda 0.136 0.244
CRAB 2 (40.0) 2 (100.0) 4 (67.7) 2 (50.0)
MRSA 1 (20.0) 0 0 1 (25.0)
CRPA 1 (20.0) 0 1 (16.7) 0
VRE 1 (20.0) 0 1 (16.7) 1 (25.0)
CRE 0 0 0 1 (25.0)
Sepsis at admission 10 (62.5) 6 (33.3) .089 11 (50.0) 10 (47.6) 0.876
Healthcare-associated infection 5 (31.3) 4 (22.2) 0.551 7 (31.8) 7 (33.3) 0.916
Antibiotic use at the time of study 13 (81.3) 13 (72.2) 0.387 16(72.7) 14 (70.0) 0.845
Clinical outcomes
New-onset sepsisb 4 (25.0) 6 (33.3) 0.595 9 (40.9) 5 (23.8) 0.232
Sites of infection 0.335 0.713
Respiratory tract 3 (75.0) 5 (83.3) 6 (66.7) 4 (80.0)
Urinary tract 1 (0.0) 0 1 (11.1) 1 (20.0)
Wound infection 0 0 2 (22.2) 0
Bloodstream infection 0 1 (16.7) 0 0
Colonized MDROs related sepsisc 2 (50.0) 1 (16.7) 0.260 1 (22.1) 1 (20.0) 0.923
Pathogens isolated from
patients with new-onset sepsis
0.350 0.286
Acinetobacter species 1 (25.0) 1 (16.7) 3 (33.3) 0
Stenotrophomonas species 0 1 (16.7) 1 (11.1) 0
Pseudomonas aeruginosa 1 (25.0) 0 1 (11.1) 0
MRSA 1 (25.0) 0 0 1 (20.0)
Enterococcus species 1 (25.0) 0 0 0
Enterobacteriaceae 0 2 (33.4) 4 (44.4) 3 (60.0)
No organisms isolated 0 2 (33.4) 0 1 (20.0)
30-d mortalityd 4 (25.0) 6 (33.3) 0.595 5 (22.7) 6 (28.6) 0.661
a Includes types of MDROs isolated from colonized patients within 3 months before admission to the study bed. One patient (Patient A)
was colonized with both MRSA and CRAB.
b Indicates that sepsis developed 48 hours after admission to or within 48 hours of leaving the study bed.
c Indicates percentage of new-onset sepsis caused by the same MDROs colonizing the patient.
d Indicates crude mortality after admission to assigned beds.
Data are presented as n (%) or mean (SD).
APACHE IIZ Acute Physiology and Chronic Health Evaluation II; COPDZ chronic obstructive pulmonary disease; CRABZ carbapenem-
resistant Acinetobacter calcoaceticus baumannii complex; CRE Z carbapenem-resistant Enterobacteriaceae; CRPA Z carbapenem-
resistant Pseudomonas aeruginosa; DM Z diabetes mellitus; ESRD Z end-stage renal disease; ICU Z intensive care unit;
MDROZ multidrug-resistant organisms; MRSAZ methicillin-resistant Staphylococcus aureus; VREZ vancomycin-resistant enterococci.
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Figure 6. Changes in mean bacterial colony counts (CFUs/100 cm2) over time during the pre-intervention period (April 1 to July 15)
and the intervention period (July 22 to October 31). CFUZ colony forming unit.
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+ MODELmolecular techniques to link these MDROs to patients
colonized by MDROs from the community.30 Thus, MDROs
can spread from a hospital to the community and from the
community to a hospital. Previous studies showed that pa-
tients colonized or infected with an MDRO can serve as
sources of environmental contamination in hospitals.8,31e33
Surfaces and textiles that have been coated with Bio-Kil can
reduce the likelihood of contamination of the hospital
environment, especially when they are used or worn by
heavily colonized patients. Reduction of the bacterial
burden in one area of a hospital environment can reduce
the total bacterial burden by interrupting the chain of
transmission. Future studies should be conducted to assess
the benefit of these self-disinfection surfaces when present
at the time of admission of patients from communities with
a high prevalence of MDROs.
Finally, we found that the incidence of new-onset sepsis
was markedly, although not statistically, lower in the study
rooms, despite the fact that patients admitted to study
rooms were significantly sicker (higher APACHE II scores at
admission) and significantly older. Previous research indi-
cated that the sources of pathogens causing HAIs in the ICU
were patient endogenous flora (40e60%), cross-infection
via the hands of personnel (20e40%), antibiotic-driven
changes in flora (20e25%), and other sources, including
contamination of the environment (20%).34 Nevertheless,
bacterial colonization is still an important step in the
development of infection in susceptible hosts. Even though
Bio-Kil effectively reduced the bacterial burden and pro-
portion of MDROs in ICU surroundings, it did not significantly
reduce the incidence of HAIs in our study.
There were several limitations in this study. First, this
was a single-center study involving a small sample size of
patients. Second, patients were also followed-up with for a
relatively short duration. Third, although the frequency of
changing pillowcases was increased from every other day to
daily beginning the 2nd week of the pre-intervention period,Please cite this article in press as: Lee W-S, et al., Bio-Kil, a nano-
multidrug-resistant organisms in intensive care units, Journal of Mic
10.1016/j.jmii.2016.04.008the duration of the pre-intervention period (83 days;
changes every other day) became 76 days (changes every
day), and the intervention period was also 77 days (no
change). The study background and duration of both pe-
riods (76 vs. 77) was nearly as the same. The clinical sta-
tistical analysis of both groups was not affected
significantly. Decontamination and disinfection of hospital
environmental surfaces is an important infection-control
measure. During the intervention period, the incidence of
new-onset sepsis decreased in the study rooms and
increased in the control rooms (from 33% to 23.8% vs. from
25% to 40.9%; p Z 0.001). Nevertheless, to the best of our
knowledge, this is the first study evaluating the potential
use of a nano-based environmental disinfectant product in
the prevention of HAIs.
In conclusion, application of Bio-Kil reduced the envi-
ronmental bacterial burden in ICUs, but did not reduce the
incidence of HAIs. Proven hospital control measures, such
as tighter protocols for sterilization of fomites and strict
adherence to hand-washing protocols, should be used to
reduce environmental colonization by MDROs.Conflicts of interest
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